Medical Condition News

RSS

New study: Only one out of 1,900 could claim ideal heart health

Only one out of more than 1,900 people evaluated met the American Heart Association definition of ideal cardiovascular health, according to a new study led by researchers at the University of Pittsburgh School of Medicine. Their findings were recently published online in Circulation.

19 Feb 2011

Eating tissue to stay thin

In a recent interview on CNN, Janet Jackson talks about the extreme measures some women in Hollywood take to achieve and maintain a thin body. She says some are even eating Kleenex to stay full so they don't feel hungry. Kimberly Dennis, M.D., and Medical Director at Timberline Knolls Residential Treatment Center, a residential treatment center for eating disorders and addictions, warns about the dangers of this behavior, and says there might be deeper problems hidden below the surface.

19 Feb 2011

Genzyme reports 3-year follow-up data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme Corporation today announced three-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate. Sustained or further improvements were observed across all endpoints, including bone disease, at the three-year timepoint.

19 Feb 2011

Heart And Stroke Foundation praises federal government for tobacco package warning system

The Heart and Stroke Foundation of Canada today applauded the federal government for taking the next step towards the implementation of a renewed tobacco package warning system.

19 Feb 2011

Study reports 9,500 injuries, 100 deaths related to crib products in the U.S.

Parents and caregivers have traditionally relied on cribs, playpens and bassinets to protect children while they sleep. The massive crib recalls followed by the announcement in December 2010 by the United States Consumer Product Safety Commission to ban drop-side cribs have caused many families to question the safety of these products.

19 Feb 2011

Early diagnosis can delay or halt progression of macular degeneration

February is Age-related Macular Degeneration and Low Vision Awareness month, providing an opportunity to inform and educate the public on the leading cause of vision loss for adults over the age of 65. Today, over 15 million of these adults suffer from age-related macular degeneration, a number that is expected to grow considerably as the baby boomer generation begins heading into retirement age. While the risks are growing, awareness and education is key to treating and saving the eyesight of millions.

19 Feb 2011

PBMI awards CVS Caremark and ArcelorMittal the 2011 Rx Benefit Innovation Award

CVS Caremark announced today that the Pharmacy Benefit Management Institute (PBMI) awarded the company and its PBM client ArcelorMittal, the world's largest steel company, the 2011 Rx Benefit Innovation Award. The award recognizes the Pharmacy Advisor program, which was developed by CVS Caremark to manage costs, improve medication adherence and close gaps in care for members with diabetes.

19 Feb 2011

Patients who undergo orthopedic surgeries at high-volume hospitals have better outcomes

Patients who undergo elective orthopedic surgeries at high-volume, regional hospitals have better surgical outcomes and experience fewer complications than those who undergo those surgeries at local hospitals, according to research being presented by Hospital for Special Surgery investigators at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

19 Feb 2011

FDA recognizes safety and efficacy of True Results LAP-BAND device

The True Results team of gastric band surgeons and medical weight loss experts is pleased the U.S. Food and Drug Administration has recognized the long-standing safety and effectiveness record of the LAP-BAND System.

19 Feb 2011

Cintas commits fundraising for AHA programs to promote heart health awareness

In recognition of American Heart Month, Cintas Corporation today announced it has committed to fundraising for the American Heart Association, as part of its First Aid & Safety Division's efforts to raise awareness about heart health.

19 Feb 2011

Québec-Transplant: 371 persons benefited from transplant in 2010

Thanks to 119 deceased organ donors, 371 persons benefited from a transplant in 2010. Unfortunately, there were also 46 deaths among people on the waiting list (compared to 58 in 2009), many of which could have been avoided. As of December 31, 2010, 1,241 people were registered on the single waiting list managed by Québec-Transplant.

19 Feb 2011

NY neurosurgeon performs deep brain surgeries with hand-held CO2 laser

Lee Eric Tessler, MD, a neurosurgeon specializing in the treatment of brain tumors, is among the first in metro New York to use a new advanced, hand-held CO2 (carbon dioxide) laser for surgeries on certain types of tumors that are buried deep within the base of the skull. The laser allows surgeons to remove these difficult-to-reach tumors in less time, with lower risk of complications, less anesthesia and a smaller possibility of damage to surrounding healthy brain and nerve tissue.

19 Feb 2011

New studies unveil latest information on hip care at AAOS meeting

At today's 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) three new studies unveil the latest in hip care.

19 Feb 2011

How Huntington's disease proteins move from cell to cell

One bad apple is all it takes to spoil the barrel. And one misfolded protein may be all that's necessary to corrupt other proteins, forming large aggregations linked to several incurable neurodegenerative diseases such as Huntington's, Parkinson's and Alzheimer's.

19 Feb 2011

Author provides tips to combat symptoms of seasonal affective disorder

Winter's chill, dark days, devoid of sunshine can send the best of us spiraling into a bad case of the blues. But those dreary winter months - particularly, February - can debilitate people living with depression.

19 Feb 2011

FDA grants CSL Behring marketing approval for Corifact in treatment of congenital FXIII deficiency

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Corifact™, Factor XIII Concentrate (Human), for the routine prophylactic treatment of congenital factor XIII (FXIII) deficiency. Corifact, already available for use in 12 countries throughout the world under the trade name Fibrogammin®- P, is the first and only FXIII concentrate approved in the U.S.

19 Feb 2011

ADAO applauds U.S. Senate for introduction of resolution recognizing National Asbestos Awareness Week

The Asbestos Disease Awareness Organization, combining education, advocacy and community as the largest U.S. organization serving as the voice of asbestos victims, today applauds Senator Max Baucus and cosponsors for introducing a resolution that declares the first week of April as "National Asbestos Awareness Week" and seeks to "raise public awareness about the prevalence of asbestos-related diseases and the dangers of asbestos exposure."

19 Feb 2011

American Cancer Society receives AAHPM Presidential Citation Award for palliative care research

The American Cancer Society has been selected to receive a Presidential Citation Award from American Academy of Hospice and Palliative Medicine recognizing the Society's commitment to support research to address quality of life issues and to promote patient-centered care.

19 Feb 2011

New study identifies factors that predict dancer ability to return to work after hip arthroscopy

A new study has identified factors that predict the ability of a professional dancer to return to professional performance after hip arthroscopy surgery. The study by Hospital for Special Surgery investigators will be presented at the American Academy of Orthopaedic Surgeons annual meeting, held Feb. 15-19 in San Diego, Calif.

19 Feb 2011

Deep brain stimulation therapy promising against severe OCD

When obsessive-compulsive disorder is of crippling severity and drugs and behavior therapy can't help, there has been for just over a year a thread - or rather a wire - of hope. By inserting a thin electrode deep into the brain, doctors can precisely deliver an electrical current to a cord of the brain's wiring and soften the severity of the symptoms. "Deep brain stimulation" therapy for OCD won Food and Drug Administration approval in 2009 for extreme cases under its humanitarian device exemption.

19 Feb 2011